Item 8.01 Other Events.
On January 18, 2023, Ensysce Biosciences, Inc. delivered a presentation entitled
"Improving Prescription Drug Safety Through Chemistry" to investors. A copy of
the presentation is filed as Exhibit 99 to this Current Report on Form 8-K and
is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Exhibit No. Description
99 Investor Presentation dated January 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
2
© Edgar Online, source Glimpses